Delivery Order SPE2DB24D8002-SPE2DB25FJNEP

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a period of performance through January 24, 2025 and a ceiling value of $2,585.80. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,203.54 and a period of performance through February 4, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,608.64 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on June 6, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,039.84 and a period of performance through October 21, 2024. Dakota Drug, Inc. is also the holder of a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,274.39, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) vehicle awarded to Dakota Drug, Inc....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,392.45, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on January 8, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed Forces...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) under the DLA Troop Support Medical's ECAT Generation V Program. The contract is for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,539.84 and a period of performance through February 11, 2025. Dakota Drug, Inc. also holds a larger single-award Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,775.97 firm fixed-price contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 9, 2024. Dakota Drug, Inc. also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the Troop Support Medical's ECAT Generation...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The contract, valued at $1,747.34, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, holding a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $3,324.97 and a performance period through November 7, 2024, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program,...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNEP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a firm fixed price of $1,467.42 and a period of performance through February 24, 2025.

This contract is associated with Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which is part of the DLA Troop Support Medical's ECAT Generation V Program. The IDC allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations, with a contract value of $999,999,999.00 and a performance period through December 31, 2025. This delivery order contract is not set-aside.

Generated 5/23/25, 10:13 AM